Pages that link to "Q37633417"
Jump to navigation
Jump to search
The following pages link to Native-like Env trimers as a platform for HIV-1 vaccine design (Q37633417):
Displayed 50 items.
- Stabilized HIV-1 envelope glycoprotein trimers for vaccine use. (Q30490942) (← links)
- Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches (Q33830824) (← links)
- Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers (Q33907694) (← links)
- Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer (Q38290294) (← links)
- Chemical optimization of macrocyclic HIV-1 inactivators for improving potency and increasing the structural diversity at the triazole ring (Q38647724) (← links)
- Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. (Q38708708) (← links)
- The HIV-1 envelope glycoprotein structure: nailing down a moving target (Q39108789) (← links)
- Structural principles controlling HIV envelope glycosylation (Q39211319) (← links)
- Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1. (Q40058876) (← links)
- Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer (Q40061438) (← links)
- HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers (Q40089181) (← links)
- The quest for an antibody-based HIV vaccine (Q40354016) (← links)
- Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. (Q41611835) (← links)
- cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate (Q46067893) (← links)
- The Neutralizing Antibody Response To the HIV-1 Env Protein. (Q46180922) (← links)
- High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers (Q46272894) (← links)
- Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. (Q46631754) (← links)
- Passive and active antibody studies in primates to inform HIV vaccines. (Q47226779) (← links)
- Optimization of the EC26-2A4 epitope in the gp41 membrane proximal external region (MPER) targeted by neutralizing antibodies from an elite controller (Q47269868) (← links)
- A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques (Q47296227) (← links)
- Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations (Q47549195) (← links)
- Developing an HIV vaccine (Q47852386) (← links)
- Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. (Q50116524) (← links)
- Structure and Immune Recognition of the HIV Glycan Shield. (Q52338073) (← links)
- The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses. (Q52584646) (← links)
- Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. (Q52688325) (← links)
- Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro. (Q55374996) (← links)
- Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design. (Q55512707) (← links)
- Production of complex viral glycoproteins in plants as vaccine immunogens (Q56398263) (← links)
- Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy? (Q56974226) (← links)
- Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen (Q57010966) (← links)
- RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses (Q57025317) (← links)
- DEER Spectroscopy Measurements Reveal Multiple Conformations of HIV-1 SOSIP Envelopes that Show Similarities with Envelopes on Native Virions (Q58730231) (← links)
- Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers (Q58763247) (← links)
- HIV-1 vaccine design through minimizing envelope metastability (Q59339672) (← links)
- Closing and opening holes in the glycan shield of HIV-1 envelope glycoprotein SOSIP trimers can redirect the neutralizing antibody response to the newly unmasked epitopes (Q59349684) (← links)
- HIV/AIDS Vaccines: 2018 (Q59354714) (← links)
- Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer (Q59358743) (← links)
- Harnessing post-translational modifications for next-generation HIV immunogens (Q59360730) (← links)
- The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256 (Q60301724) (← links)
- Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide (Q61795909) (← links)
- Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques (Q63740489) (← links)
- The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following Immunization (Q64062652) (← links)
- Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells (Q64068094) (← links)
- Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers (Q64228820) (← links)
- Exploitation of glycosylation in enveloped virus pathobiology (Q64359271) (← links)
- Selective use of primate CD4 receptors by HIV-1. (Q64979797) (← links)
- Protein and Glycan Mimicry in HIV Vaccine Design. (Q64983102) (← links)
- Structure-based immunogen design-leading the way to the new age of precision vaccines (Q89446935) (← links)
- Method for Quantifying Oxidized Methionines and Application to HIV-1 Env (Q89483844) (← links)